Wu Jieping Medical Foundation
OrganizationROR
Trials
Collaborator, Phase 4, Not yet recruiting, 606 people, Jul 31, 2024
Collaborator, Phase 3, Status unknown, 160 people, Sep 26, 2013
Phase 2, Status unknown, 200 people, Feb 21, 2013
Phase 2, Status unknown, 210 people, Jan 8, 2013
Collaborator, Phase 2, Completed, 96 people, Nov 20, 2009
Funded papers
Sep 22, 2026
Targeting the cardiohepatic-metabolic axis: GLP-1-based and incretin multi-agonist therapies in MASH
320.6750, Sep 17, 2026
Sep 3, 2026
320.6750.2020-11-21, Aug 29, 2026
320.6750.2024-6-50, Aug 8, 2026
Jun 20, 2026
Jun 6, 2026
Stagnation and Progression: How Glymphatic Failure Promotes Meningioma Malignancy in Aging
May 8, 2026
320.6750.2023-08-4, May 5, 2026
Apr 24, 2026
320.6750.2020-05-1, Apr 16, 2026
320.6750.2023-19-30, 320.6750, Apr 1, 2026
Metformin Induces Ferroptosis and Inhibits Malignant Progression in Diabetic Breast Cancer
320.6750.2023-18-72, Mar 30, 2026
Mar 23, 2026
Mar 5, 2026
Feb 23, 2026
320.6750, Feb 23, 2026
320.6750.2021-02-22, Feb 23, 2026
Feb 13, 2026
Influence of obesity on breast cancer development in relation to menopausal status (Review)
320.6750, Feb 9, 2026
Sources: openalex.org, api.crossref.org
Named in competing interests
Grants or research support, Nov 28, 2017
Sources: pubmed.ncbi.nlm.nih.gov